Post Intensive Care Syndrome in COVID19 Patients
PICS-COVID19
Characterization and Management of Post Intensive Care Syndrome in COVID19 Patients.
1 other identifier
observational
150
1 country
1
Brief Summary
This project is based in the implementation of a combined monitoring system (technological solutions and medical visits) in survivors of the critical illness due to the infectious disease by COVID-19. The main objective of the project is to characterize the Post-Intensive Care Syndrome (PICS) and detect early needs for specific treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2020
CompletedFirst Submitted
Initial submission to the registry
June 4, 2020
CompletedFirst Posted
Study publicly available on registry
June 9, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2022
CompletedMarch 22, 2023
March 1, 2023
1.1 years
June 4, 2020
March 21, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Change from baseline Short Form 12 Health Survey (SF12) at 12 month
Health related quality of live scale. Values are directly transformed in T scores (mean=50; SD=10), with higher scores meaning better outcome.
Every month during a 12 months follow-up period
Secondary Outcomes (4)
Change from baseline Lawton & Brody Instrumental activities of daily living scale at 12 months
Every month during a 12 months follow-up period
Change from baseline Perceived Deficits Questionnaire (PDQ) at 12 months
Every month during a 12 months follow-up period
Change from baseline Hospital Anxiety and Depression Scale (HADS) at 12 months
Every month during a 12 months follow-up period
Change from baseline Davidson Trauma Scale (DTS) at 12 months
Every month during a 12 months follow-up period. Values are from 0 to 136, with lower scores meaning better outcome.
Interventions
Participants will answer questionnaires in three areas: physical/functional, emotional status and cognitive status
Eligibility Criteria
ICU patients with COVID19
You may qualify if:
- Patients admitted to ICU for COVID 19
You may not qualify if:
- Mental health diagnosis previous to the COVID19 infection
- Acquired brain damage or neurological disease previous to the COVID19 infection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Corporació Parc Taulí
Sabadell, Barcelona, 08208, Spain
Related Publications (3)
Fernandez-Gonzalo S, Navarra-Ventura G, Goma G, Godoy-Gonzalez M, Oliveras L, Ridao Sais N, Espinal C, Fortia C, De Haro C, Ochagavia A, Jodar M, Forne C, Santos-Pulpon V, Sarlabous L, Bacardit N, Subira C, Fernandez R, Palao D, Roca O, Blanch L, Lopez-Aguilar J. Characterization of postintensive care syndrome in a prospective cohort of survivors of COVID-19 critical illness: a 12-month follow-up study. Can J Anaesth. 2024 Sep;71(9):1282-1301. doi: 10.1007/s12630-024-02811-4. Epub 2024 Sep 9.
PMID: 39251486DERIVEDNavarra-Ventura G, Godoy-Gonzalez M, Goma G, Jodar M, Sarlabous L, Santos-Pulpon V, Xifra-Porxas A, de Haro C, Roca O, Blanch L, Lopez-Aguilar J, Fernandez-Gonzalo S. Occurrence, co-occurrence and persistence of symptoms of depression and post-traumatic stress disorder in survivors of COVID-19 critical illness. Eur J Psychotraumatol. 2024;15(1):2363654. doi: 10.1080/20008066.2024.2363654. Epub 2024 Jun 17.
PMID: 38881386DERIVEDGodoy-Gonzalez M, Navarra-Ventura G, Goma G, de Haro C, Espinal C, Fortia C, Ridao N, Miguel Rebanal N, Oliveras-Furriols L, Subira C, Jodar M, Santos-Pulpon V, Sarlabous L, Fernandez R, Ochagavia A, Blanch L, Roca O, Lopez-Aguilar J, Fernandez-Gonzalo S. Objective and subjective cognition in survivors of COVID-19 one year after ICU discharge: the role of demographic, clinical, and emotional factors. Crit Care. 2023 May 15;27(1):188. doi: 10.1186/s13054-023-04478-7.
PMID: 37189173DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
SOL FERNANDEZ, PhD
Institut d'Investigació i Innovació Parc Taulí (I3PT)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 12 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Postdoctoral neuropsychology researcher
Study Record Dates
First Submitted
June 4, 2020
First Posted
June 9, 2020
Study Start
June 1, 2020
Primary Completion
June 30, 2021
Study Completion
June 1, 2022
Last Updated
March 22, 2023
Record last verified: 2023-03